Fig. 2From: New insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeuticsSchematic domain structure and PTMs sites of Hippo pathway core components. SARAH Sav/Rassf/Hpo domain; NES nuclear- exporting sequence; WW WW domain; UBA Ubiquitin-associated domain; PBD protein binding domain; HM hydrophobic motif; P-rich proline-rich region; C–C coiled-coil domain; PDZ-binding PDZ-binding motif. PTMs residue site details are listed in Table 1 Back to article page